Literature DB >> 17688728

Mortality following hip fracture surgery in patients with recent myocardial infarction.

Baskaran Komarasamy1, Mark C Forster, Colin N Esler, William M Harper, Andrew P Hall.   

Abstract

INTRODUCTION: In an elective setting, surgery is best avoided for at least 6 months following myocardial infarction. However, in the presence of a femoral neck fracture, this would most probably lead to significant complications in relation to prolonged immobilisation. There is no published mortality data for patients undergoing surgery for hip fracture following a recent myocardial infarction. The aim of this retrospective study was to assess the mortality of hip fracture patients with a recent myocardial infarction that have undergone surgery at our institution. PATIENTS AND METHODS: Between January 2003 and October 2005, 2270 patients were admitted to our unit with a proximal femoral fracture. Of these, 11 patients were found to have a recent myocardial infarction.
RESULTS: Of these 11 patients, 8 were female. The average age was 78.2 years (range, 59-90 years). Average delay from the time of infarction to operation was 11.2 days (range, 3-23 days). Mortality at 1 and 6 months was 45.4% and 63.5%, respectively. DISCUSSION: This is much higher than the overall reported mortality following proximal femur fracture. This information may be useful when planning future peri-operative care and discussing overall prognosis with patients and their relatives.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17688728      PMCID: PMC2048603          DOI: 10.1308/003588407X187720

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  18 in total

1.  Randomized controlled trial to investigate influence of the fluid challenge on duration of hospital stay and perioperative morbidity in patients with hip fractures.

Authors:  R Venn; A Steele; P Richardson; J Poloniecki; M Grounds; P Newman
Journal:  Br J Anaesth       Date:  2002-01       Impact factor: 9.166

Review 2.  Cemented or uncemented hemiarthroplasty for displaced intracapsular fractures of the hip--a systematic review.

Authors:  R J K Khan; A MacDowell; P Crossman; G S Keene
Journal:  Injury       Date:  2002-01       Impact factor: 2.586

3.  Cardiac output during hemiarthroplasty of the hip. A prospective, controlled trial of cemented and uncemented prostheses.

Authors:  D I Clark; A B Ahmed; B R Baxendale; C G Moran
Journal:  J Bone Joint Surg Br       Date:  2001-04

4.  In-hospital mortality of elderly patients with acute myocardial infarction: data from the MITRA (Maximal Individual Therapy in Acute Myocardial Infarction) registry.

Authors:  K K Haase; R Schiele; S Wagner; F Fischer; U Burczyk; R Zahn; S Schuster; J Senges
Journal:  Clin Cardiol       Date:  2000-11       Impact factor: 2.882

5.  Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study.

Authors:  J J W Roche; R T Wenn; O Sahota; C G Moran
Journal:  BMJ       Date:  2005-11-18

6.  Operative or conservative treatment for trochanteric fractures of the femur. A randomised epidemiological trial in elderly patients.

Authors:  R Hornby; J G Evans; V Vardon
Journal:  J Bone Joint Surg Br       Date:  1989-08

7.  Factors which influence mortality after subcapital hip fracture.

Authors:  D J Wood; G K Ions; J M Quinby; D W Gale; J Stevens
Journal:  J Bone Joint Surg Br       Date:  1992-03

8.  The timing of surgery for proximal femoral fractures.

Authors:  M J Parker; G A Pryor
Journal:  J Bone Joint Surg Br       Date:  1992-03

9.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1993-09-02       Impact factor: 91.245

10.  Reinfarction following anesthesia in patients with myocardial infarction.

Authors:  T L Rao; K H Jacobs; A A El-Etr
Journal:  Anesthesiology       Date:  1983-12       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.